 | | | | Vertex Pharmaceuticals Inc said on Wednesday cystic fibrosis patients in Wales would get access to the company's life-extending drugs following an agreement with the state-funded health service. | | |
| | | Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows. | | |
| | | A 17-year-old Michigan boy facing "imminent death" from vaping injuries has undergone a double lung transplant, the first in a patient suffering from the effects of e-cigarettes, a Detroit hospital said on Tuesday. | | |
| | | Britain's opposition Labour Party will pledge on Wednesday to spend an extra 26 billion pounds ($33 billion) on healthcare if it wins the Dec. 12 election, including recruiting thousands more staff, rebuilding facilities and providing new equipment. | | |
| | | (Reuters Health) - People who have trouble falling asleep or staying asleep may be more likely to have a heart attack or stroke than individuals who don't have any sleep difficulties, a recent study suggests. | | |
| | | (Reuters Health) - When surgeons cut their prescribing of opioids for pain by more than 50%, their patient-satisfaction scores didn't suffer, a small U.S. study found. | | |
| | | (Reuters Health) - White mothers may receive more pain assessments after delivery and have better access to painkillers than women from other racial and ethnic groups, two new studies suggest. | | |
| | | ESwatini has suspended animal imports from neighboring South Africa for a second time this year following another outbreak of foot and mouth disease, the mountain kingdom's agricultural ministry said on Tuesday. | | |
| | | The United States recorded 11 measles cases over a month as of Nov. 7, taking the total cases for the year to 1,261 in the worst outbreak since 1992, the Centers for Disease Control and Prevention said on Tuesday. | | |
| | | Amarin Corp Plc's fish oil-derived drug received a largely positive review from FDA staffers on Tuesday, dispelling investor fears that the company's choice of placebo in its trial could challenge the approval of its potential blockbuster. | | |
| | | Shares in Solid Biosciences Inc plunged 71% on Tuesday after a trial testing its gene therapy for a muscle-wasting disorder was halted for the second time in less than two years. | | |
|
| |
